The REMS Industry Consortium (RIC) brings together the Risk Evaluation and Mitigation Strategies industry to advance patient safety and innovation in the implementation of new drugs and biologics. By joining RIC, you can gain knowledge, experience, and professional affiliations that will put you at the forefront of REMS industry advancements. Through RIC networking opportunities, you will make vital connections with other professionals in this space who share your desire for collaboration and guidance in addressing industry challenges.
Current RIC Members include:
Aimmune Therapeutics, a Nestle Health Sciences Company
Alexion - Astra Zeneca Rare Disease Unit
Apellis Pharmaceuticals, Inc.
Ascend Laboratories LLC, a subsidiary of Alkem Laboratories Ltd
Bristol Myers Squibb
Chinook Therapeutics, Inc.
Hikma Pharmaceuticals USA Inc.
Tasman Pharma Inc.
Zydus Pharmaceuticals USA Inc.
Current Industry Partners include:
Axian Consulting, Ltd.
Compliance Architects, LLC
Metis Consulting Services, Inc.
Quandary Peak Research, Inc.
Shephard Safety Services at Two Labs
United BioSource, LLC